Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rebecca M Richards"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/82e355df71634ede86eb223d9b31c03d
Autor:
Hongyan Liu, Colleen Callahan, Shannon L Maude, Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Yimei Li, Kara Lynn Davis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Immunocompromised patients are at increased risk of SARS-CoV-2 infections. Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B
Externí odkaz:
https://doaj.org/article/6172d8b90c9540918dcb40c5c533faf9
Autor:
Liora M. Schultz, Sneha Ramakrishna, Reema Baskar, Rebecca M Richards, Jennifer Moon, Christina Baggott, Michelle Fujimoto, Michael Kunicki, Amy Li, Sneha Jariwala, Courtney Erickson, Ashley Jacobs, Karen Yamabe, Valentin Barsan, Robbie G. Majzner, Emily L. Egeler, Sharon Mavroukakis, Zachary Ehlinger, Warren D. Reynolds, Bita Sahaf, Lori Muffly, Matthew J Frank, Anne-Louise Gramstrup, Harshini Chinnasamy, Shabnum Patel, David B. Miklos, Steven A. Feldman, Crystal L. Mackall, Kara L. Davis
Publikováno v:
Blood. 140:10300-10302
Autor:
Crystal L. Mackall, Ravindra Majeti, Robbie G. Majzner, Ansuman T. Satpathy, Howard Y. Chang, Poul H. Sorensen, Wan-Jen Hong, Jie Liu, Htoo Zarni Oo, Mads Daugaard, Elena Sotillo, Amy Fan, Peng Xu, Kevin R. Parker, Katherine A. Freitas, Feifei Zhao, Rebecca M. Richards
Supplemental figures and legends in one document
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a648a9aba5801dbaef9a405c3d987d75
https://doi.org/10.1158/2643-3230.22543087
https://doi.org/10.1158/2643-3230.22543087
Autor:
Crystal L. Mackall, Ronald D. Vale, Alexander R. Dunn, Peng Xu, Rachel C. Lynn, Johanna Theruvath, Volker Wiebking, Sang M. Nguyen, Sabine Heitzeneder, Rebecca M. Richards, Aidan M. Tousley, Evan W. Weber, Meena Kadapakkam, June H. Myklebust, Louai Labanieh, Vipul T. Vachharajani, Rui Dong, Elena Sotillo, Skyler P. Rietberg, Robbie G. Majzner
Supplemental Table 1 Supplementary Figures 1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::311f40ebf949712905c9428d4941d39e
https://doi.org/10.1158/2159-8290.22535654.v1
https://doi.org/10.1158/2159-8290.22535654.v1
Autor:
Crystal L. Mackall, Ronald D. Vale, Alexander R. Dunn, Peng Xu, Rachel C. Lynn, Johanna Theruvath, Volker Wiebking, Sang M. Nguyen, Sabine Heitzeneder, Rebecca M. Richards, Aidan M. Tousley, Evan W. Weber, Meena Kadapakkam, June H. Myklebust, Louai Labanieh, Vipul T. Vachharajani, Rui Dong, Elena Sotillo, Skyler P. Rietberg, Robbie G. Majzner
Insufficient reactivity against cells with low antigen density has emerged as an important cause of chimeric antigen receptor (CAR) T-cell resistance. Little is known about factors that modulate the threshold for antigen recognition. We demonstrate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f70c30aecf09a358b25065ab2c1e623f
https://doi.org/10.1158/2159-8290.c.6547904.v1
https://doi.org/10.1158/2159-8290.c.6547904.v1
Autor:
Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Colleen Callahan, Hongyan Liu, Yimei Li, Kara Lynn Davis, Shannon L Maude
BackgroundImmunocompromised patients are at increased risk of SARS-CoV-2 infections. Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed3656e1803cbd4367854da9f5c312fb
https://hdl.handle.net/10281/424338
https://hdl.handle.net/10281/424338
Autor:
Agnes Reschke, Rebecca M. Richards, Stephanie M. Smith, Adrienne H. Long, Lianna J. Marks, Liora Schultz, Jennifer L. Kamens, Catherine Aftandilian, Kara L. Davis, Tanja Gruber, Kathleen M. Sakamoto
Publikováno v:
Frontiers in Oncology. 12
Clinical pathways are evidence-based tools that have been integrated into many aspects of pediatric hospital medicine and have proven effective at reducing in-hospital complications from a variety of diseases. Adaptation of similar tools for specific
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Patients with high risk neuroblastoma have a poor prognosis and survivors are often left with debilitating long term sequelae from treatment. Even after integration of anti-GD2 monoclonal antibody therapy into standard, upftont protocols, 5-year over
Externí odkaz:
https://doaj.org/article/57c77116b2ae439aa2e4a7ff9af80f6a